Back
Elixirr International Plc Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Sell
10
ELXXF
Elixirr International Plc
Last Price:
$8.00
Seasonality Move:
0.96%
Sell
46
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$61.04
Seasonality Move:
-2.16%
Sell
10
Elixirr International Plc (ELXXF)
is a Sell
Is Elixirr International Plc a Buy, Sell or Hold?
-
The current Elixirr International Plc [ELXXF] share price is $8.00. The Score for ELXXF is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
-
ELXXF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $61.03. The Score for ARWR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ELXXF Stock Price Chart
What is Elixirr International Plc's stock price today?
-
The Elixirr International Plc share price today is $8.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ELXXF is experiencing slight buying pressure.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $61.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing selling pressure, which indicates risk of future bearish movement.
ELXXF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.86 | Sell |
| Relative Strength Index (14 RSI): | 0.75 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.11 - 11.95) | Sell |
| Bollinger Bands (100): | (10.08 - 11.64) | Sell |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 52.24 | Buy |
| Chaikin Money Flow: | -832975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.52 - 62.66) | Buy |
| Bollinger Bands (100): | (52.16 - 69.78) | Buy |
ELXXF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.83 | Sell |
| 20-day SMA: | 10.33 | Sell |
| 50-day SMA: | 10.89 | Sell |
| 200-day SMA: | 10.21 | Sell |
| 8-day EMA: | 8.74 | Sell |
| 20-day EMA: | 9.82 | Sell |
| 50-day EMA: | 10.53 | Sell |
| 200-day EMA: | 10.32 | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.99 | Buy |
| 20-day SMA: | 58.47 | Buy |
| 50-day SMA: | 62.54 | Sell |
| 200-day SMA: | 43.35 | Buy |
| 8-day EMA: | 60.24 | Buy |
| 20-day EMA: | 59.83 | Buy |
| 50-day EMA: | 60.7 | Buy |
| 200-day EMA: | 47.94 | Buy |
Elixirr International Plc Earnings Growth & ELXXF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.10 per share, a decrease this year of $3.21 per share, and a decrease next year of $1.06 per share.
Elixirr International Plc Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||